Company News for Aug 4, 2022

REGN EXC MRNA

  • Shares of Moderna, Inc. (MRNA - Free Report) surged 16% after it announced a $3 billion share buyback plan.
  • Regeneron Pharmaceuticals, Inc.’s (REGN - Free Report) shares rose 5.9% after it reported second-quarter 2022 earnings of $9.77 per share, beating the Zacks Consensus Estimate of $8.53 per share.
  • Shares of Horizon Therapeutics Public Limited Company plummeted 18.5% after it reported second-quarter 2022 revenues of $876.4 million, missing the Zacks Consensus Estimate of $938.8 million.
  • Exelon Corporation’s (EXC - Free Report) shares fell 3.3% after it reported second-quarter 2022 earnings of $0.44 per share, missing the Zacks Consensus Estimate of $0.46 per share.

5 Stocks Set to Double

Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>